サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1747305

動物用麻酔薬市場：麻酔薬クラス別、動物タイプ別、投与経路別、用途別、流通チャネル別、エンドユーザー別、地域別

Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, By Animal Type, By Route of Administration, By Application, By Distribution Channel, By End User, By Geography

出版日
ページ情報
英文 166 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.36円
動物用麻酔薬市場：麻酔薬クラス別、動物タイプ別、投与経路別、用途別、流通チャネル別、エンドユーザー別、地域別
出版日: 2025年05月23日
発行: Coherent Market Insights
ページ情報: 英文 166 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用麻酔薬の世界市場は、2025年には5億1,120万米ドルと推定され、2032年までには7億8,920万米ドルに達すると予測され、2025年から2032年にかけてCAGR6.4％で成長すると予測されています。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 5億1,120万米ドル
実績データ 2020年～2024年/td> 予測期間 2025年～2032年
予測期間：2025年～2032年 CAGR： 6.40% 2032年の金額予測 7億8,920万米ドル

世界の動物用麻酔薬市場は、高度な獣医学的治療に対する需要の増加と伴侶動物の慢性疾患の有病率の上昇に牽引され、近年著しい成長を遂げています。動物用麻酔薬は、様々な外科手術において重要な役割を果たし、医療介入中の動物の安全性と快適性を確保しています。これらの薬剤は、麻酔の誘発と維持に使用され、鎮痛と筋弛緩をもたらし、獣医師が複雑な手術や診断手順を実行できるようにします。この市場には、注射用麻酔薬、吸入麻酔薬、局所麻酔薬など幅広い麻酔薬が含まれ、それぞれに独自の特性と用途があります。ペットの飼育率が世界的に上昇を続け、飼い主が愛玩動物のために高度ヘルスケアへの投資を望むようになるにつれ、動物用麻酔薬の需要は今後数年間でさらに拡大すると予想されます。

市場力学

世界の動物用麻酔薬市場は、その成長を促進し、課題をもたらし、機会を提供するいくつかの重要な要因の影響を受けています。主な促進要因の1つは、ペット数の増加と、動物のための高品質な医療への投資に対する飼い主の意欲に後押しされた、高度な獣医学的治療に対する需要の増加です。さらに、コンパニオンアニマルの間で、がん、心血管疾患、整形外科疾患などの慢性疾患の有病率が上昇しているため、外科手術の件数が増加しており、動物用麻酔薬の需要をさらに押し上げています。しかし、市場には麻酔薬や麻酔器具のコストが高いなどの抑制要因もあり、コストに敏感な地域では導入が制限される可能性があります。さらに、動物用麻酔薬の標準化されたプロトコルがないことや、特定の麻酔薬に関連する潜在的な副作用が市場成長の課題となる可能性もあります。こうした市場抑制要因にもかかわらず、市場はメーカーやサプライヤーに大きなチャンスを与えています。革新的でより安全な麻酔薬の開発と低侵襲手術手技への注目の高まりが、市場拡大の原動力になると予想されます。さらに、新興国における動物用麻酔薬の需要の高まりは、動物病院やクリニックのネットワークの拡大と相まって、市場プレーヤーに有利な成長見通しを提供しています。

本調査の主な特徴

  • 本レポートでは、世界の動物用麻酔薬市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模および複合年間成長率（CAGR%）を提供しています。
  • 異なるセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の動物用麻酔薬市場の主要企業をプロファイルしています。
  • このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
  • 動物用麻酔薬の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は、世界の動物用麻酔薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の動物用麻酔薬市場、麻酔薬クラス別、2020年～2032年

  • 全身麻酔
  • バルビツール酸
  • 解離剤（例：ケタミン）
  • 吸入剤（例：イソフルラン、セボフルラン）
  • 局所麻酔薬
  • リドカイン
  • ブピバカイン
  • 補助剤
  • 鎮静剤（例：デクスメデトミジン、メデトミジン）
  • 鎮痛剤（例：オピオイド、NSAID）
  • 神経筋遮断薬

第5章 世界の動物用麻酔薬市場、動物タイプ別、2020年～2032年

  • コンパニオンアニマル
  • 家畜

第6章 世界の動物用麻酔薬市場、投与経路別、2020年～2032年

  • 静脈内
  • 筋肉内
  • 吸入
  • 局所
  • その他（経口術前鎮静）

第7章 世界の動物用麻酔薬市場、用途別、2020年～2032年

  • 外科手術
  • 診断手順
  • 疼痛管理

第8章 世界の動物用麻酔薬市場、流通チャネル別、2020年～2032年

  • 動物用医薬品店
  • オンライン薬局
  • 小売薬局

第9章 世界の動物用麻酔薬市場、エンドユーザー別、2020年～2032年

  • 病院/診療所
  • 学術・研究機関
  • 移動獣医ユニット
  • その他

第10章 世界の動物用麻酔薬市場、地域別、2020年～2032年、金額

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第11章 競合情勢

  • Zoetis
  • Merck Animal Health
  • Elanco
  • Bayer Animal Health
  • Vetoquinol
  • Dechra Pharmaceuticals
  • Cegelec
  • Jorgensen Laboratories
  • Abaxis
  • VetMedin
  • Henry Schein Animal Health
  • MWI Animal Health
  • IDEXX Laboratories
  • Neogen Corporation
  • Virbac

第12章 アナリストの提言

  • 運命の輪
  • アナリストの見解
  • Coherent Opportunity Map

第13章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7971

Global Veterinary Anesthesia Drugs Market is estimated to be valued at USD 511.2 Mn in 2025 and is expected to reach USD 789.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 511.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 789.2 Mn

The global veterinary anesthesia drugs market has witnessed significant growth in recent years, driven by the increasing demand for advanced veterinary care and the rising prevalence of chronic diseases among companion animals. Veterinary anesthesia drugs play a crucial role in various surgical procedures, ensuring the safety and comfort of animals during medical interventions. These drugs are used to induce and maintain anesthesia, providing pain relief and muscle relaxation, enabling veterinarians to perform complex surgeries and diagnostic procedures. The market encompasses a wide range of anesthetic agents, including injectable anesthetics, inhalation anesthetics, and local anesthetics, each with unique properties and applications. As pet ownership continues to rise globally and pet owners become more willing to invest in advanced healthcare for their furry companions, the demand for veterinary anesthesia drugs is expected to grow further in the coming years.

Market Dynamics

The global veterinary anesthesia drugs market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing demand for advanced veterinary care, fueled by the growing pet population and the willingness of pet owners to invest in high-quality medical treatments for their animals. Moreover, the rising prevalence of chronic diseases among companion animals, such as cancer, cardiovascular disorders, and orthopedic conditions, has led to a higher number of surgical procedures, further boosting the demand for veterinary anesthesia drugs. However, the market also faces certain restraints, including the high cost of anesthetic drugs and equipment, which can limit their adoption in cost-sensitive regions. Additionally, the lack of standardized protocols for veterinary anesthesia and the potential side effects associated with certain anesthetic agents may pose challenges to market growth. Despite these restraints, the market presents significant opportunities for manufacturers and suppliers. The development of innovative and safer anesthetic drugs, along with the increasing focus on minimally invasive surgical techniques, is expected to drive market expansion. Furthermore, the growing demand for veterinary anesthesia drugs in emerging economies, coupled with the expanding network of veterinary clinics and hospitals, offers lucrative growth prospects for market players.

Key Features of the Study

  • This report provides in-depth analysis of the global veterinary anesthesia drugs market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary anesthesia drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis, Merck Animal Health, Elanco, Bayer Animal Health, Vetoquinol, Dechra Pharmaceuticals, Cegelec, Jorgensen Laboratories, Abaxis, VetMedin, Henry Schein Animal Health, MWI Animal Health, IDEXX Laboratories, Neogen Corporation, and Virbac
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary anesthesia drugs market

Market Segmentation

  • Anesthetic Drug Class Insights (Revenue, USD Mn, 2020 - 2032)
    • General Anesthetics
    • Barbiturates
    • Dissociative Agents (e.g., Ketamine)
    • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
    • Local Anesthetics
    • Lidocaine
    • Bupivacaine
    • Adjunctive Agents
    • Sedatives (e.g., Dexmedetomidine, Medetomidine)
    • Analgesics (e.g., Opioids, NSAIDs)
    • Neuromuscular Blockers etc.
  • Animal Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Companion Animals
    • Livestock Animals
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Intravenous
    • Intramuscular
    • Inhalation
    • Topical
    • Others (Oral-pre-surgical sedation)
  • Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Surgical Procedures
    • Diagnostic Procedures
    • Pain Management
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Veterinary Drug Stores
    • Online Pharmacies
    • Retail Pharmacies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals/Clinics
    • Academic & Research Institutes
    • Mobile Veterinary Units
    • others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Zoetis
    • Merck Animal Health
    • Elanco
    • Bayer Animal Health
    • Vetoquinol
    • Dechra Pharmaceuticals
    • Cegelec
    • Jorgensen Laboratories
    • Abaxis
    • VetMedin
    • Henry Schein Animal Health
    • MWI Animal Health
    • IDEXX Laboratories
    • Neogen Corporation
    • Virbac

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class
    • Global Veterinary Anesthesia Drugs Market, By Animal Type
    • Global Veterinary Anesthesia Drugs Market, By Route of Administration
    • Global Veterinary Anesthesia Drugs Market, By Application
    • Global Veterinary Anesthesia Drugs Market, By Distribution Channel
    • Global Veterinary Anesthesia Drugs Market, By End User
    • Global Veterinary Anesthesia Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Veterinary Anesthesia Drugs Market, By Anesthetic Drug Class, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • General Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Barbiturates
  • Dissociative Agents (e.g., Ketamine)
  • Inhalant Agents (e.g., Isoflurane, Sevoflurane)
  • Local Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lidocaine
  • Bupivacaine
  • Adjunctive Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Sedatives (e.g., Dexmedetomidine, Medetomidine)
  • Analgesics (e.g., Opioids, NSAIDs)
  • Neuromuscular Blockers

5. Global Veterinary Anesthesia Drugs Market, By Animal Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Companion Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Livestock Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Veterinary Anesthesia Drugs Market, By Route of Administration, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inhalation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others(Oral-pre-surgical sedation)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Veterinary Anesthesia Drugs Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Procedures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Veterinary Anesthesia Drugs Market, By Distribution Channel, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Veterinary Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Veterinary Anesthesia Drugs Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Mobile Veterinary Units
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Veterinary Anesthesia Drugs Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Anesthetic Drug Class, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Animal Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Zoetis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cegelec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jorgensen Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abaxis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • VetMedin
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Henry Schein Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MWI Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us